fbpx Start at the End: Thinking Commercial during Discovery and Development - Videos | JLABS

Start at the End: Thinking Commercial during Discovery and Development

11/03/2021
00:55:31
Start at the End_ Thinking Commercial during Discovery and Development_CC_EN

Start at the End: Thinking Commercial during Discovery and Development

When your product launches 5, 8 or 10 years from now, what do you intend the label to read? You cannot make any commercial claim if it is not scientifically proven and written in the label. As early as discovery and throughout development, entrepreneurs and startups would do well to keep their end-goal in mind.

What is the exact target population, indication and formulation? Which benefits, risks and tolerability concerns are acceptable? What are unique selling points compared to competitors? And who is going to pay?

During this session our speakers discuss their views on the importance of ascertaining early how health interventions will potentially add value in the future marketplace. Developers need to consider all the stakeholders — Patients, Partners, Prescribers and Payers. Having a clear picture could help guide business decisions and business development opportunities.

Within the Janssen Pharmaceutical Companies of Johnson & Johnson the Target Product Profile (TPP) is the go-to document describing the end-goal. The TPP is a concise communication tool designed with the aim to demonstrate key value drivers and attributes of the intended product. Our speakers discuss what this document looks like and how it could guide prioritization and decision making.

Throughout discovery and development, startups can work together with many partners such as investors, R&D partners and service providers. During a panel  different stakeholders discuss how the TPP could help startups and their collaborators stay focused and aligned.

Check out more On-Demand Webinars

 

Please note: This is the recording of a webinar which took place on October 28, 2021.

You are watching a rebroadcast of the webinar. There will not be a live Q&A session following the presentation. If you have any questions for the speakers, please email  [email protected]

DISCLAIMER: The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only.  This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates.  The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.


Related content